Welcome in, today is Tuesday, August fourth, and we begin with Beiersdorf, where Cosmetics Business reports a guidance cut arriving alongside fresh spending behind Nivea. Cosmetics Business reports Beiersdorf has cut its sales guidance for the current financial year. Organic sales at the consumer business division, and across the group, are now expected to decline in the low single digits. Previous guidance was flat to slightly growing. The same reporting puts a number on the fix. Another one hundred million euros goes into Nivea consumer-facing activation, opening a second phase of the brand's rebalancing programme, aimed at returning the heritage brand to growth within eighteen months. That spend reads straight through to margin. Per that account, consumer division EBIT margin is now guided to eleven percent, down from thirteen point six percent last year, and group margin to eleven point eight percent, down from fourteen. Guidance for the tesa division was left unchanged. In a market update, the company said the global skin care market has remained challenging, citing further impacts from the Middle East crisis on consumer sentiment, consumption and costs. It said its executive board resolved to launch the next phase to stimulate Nivea's growth momentum on a global scale, and it expects to stabilise margin and return to net sales growth in twenty twenty seven. Industry reaction leans toward reading the cut as macro rather than brand-specific, with recurring mentions of consumer softness, price pressure and regional trade disruption. Also today, a very different set of numbers out of Seoul. Global Cosmetics News reports Amorepacific Group lifted second-quarter revenue fourteen point six percent year on year, to one point two five trillion Korean won, with operating profit up fifty three point three percent to one hundred twenty two point eight billion won. That account credits strong domestic demand alongside accelerating international expansion across the Americas, EMEA and Japan. The shape of that is the part worth marking. Profit rising close to four times faster than the top line, on growth attributed to Western and Japanese markets, is a read on how far the K-beauty export runway now extends beyond its historic engine in China. Separately, to Brazil, where the question is whether a drugstore estate can carry prestige. The Rio Times reports RD Saúde, owner of the Raia and Drogasil pharmacy brands, opens a premium beauty concept store in São Paulo on Wednesday. Per that reporting, the site, called Raia Conceito, runs three hundred sixty four square metres, more than double a standard unit, with over sixty five percent of the floor given to beauty rather than medicine. It adds more than two thousand five hundred beauty products and fifty new brands, thirty three of them premium, spanning imported perfumery, dermocosmetics and Korean and Japanese skin care, staffed by about ten trained consultants and fitted with testing benches and a skin-diagnostic device. The same account says RD expects average basket two to three times a normal pharmacy, with beauty at roughly forty percent of store sales against about twenty four percent today. Executives compared the format to Boots and declined to frame it as an attack on Sephora. More concept stores are planned later this year. Now, a few more headlines moving the trade today. Cosmetics Business reports fragrance brand Dossier has named former Johnson and Johnson and Coty executive Stefano Curti executive chairman, leading its board following its acquisition by American Pacific Group. Global Cosmetics News reports LVMH has sold French fashion house Patou back to beauty entrepreneur Dilesh Mehta, reversing the majority stake it acquired in twenty eighteen. WWD reports Bubble and e.l.f. Cosmetics are launching a limited-edition trio, Hybrid Holy Grails, exclusive to Target, combining hero products from both brands in single bottles. Following our earlier report on K18's hair longevity serum, Glossy argues well-funded innovators are now racing to define the category itself, a shift that account says is still being drawn. And finally, WWD reports Iris Ventures has taken a minority stake in Krème, the organic French pharmacy brand using probiotics for ultra-sensitive skin.